BTK Inhibitor

Pirtobrutinib (LOXO-305)

Phase 3

Enrolling
CLL/SLL
Pirtobrutinib (LOXO-305)
Enrolling
CLL/SLL
Pirtobrutinib (LOXO-305)
Enrolling
CLL/SLL
Pirtobrutinib (LOXO-305)
Enrolling
CLL/SLL
Pirtobrutinib (LOXO-305)
Enrolling
MCL
Pirtobrutinib (LOXO-305)

Phase 2

Enrolling
CLL/SLL or NHL
Pirtobrutinib (LOXO-305)

Need additional information or have a question:

The safety and efficacy of the agents under investigation have not been established. There is no guarantee that the agents will receive regulatory approval and become commercially available for the uses being investigated.